ST葫芦娃：“昂丹司琼口溶膜” 和“依达拉奉右莰醇注射用浓溶液”是公司与杭州康领先共同开发的项目

Core Viewpoint - The company ST葫芦娃 is collaborating with Hangzhou Kanglixian Pharmaceutical Technology Co., Ltd. to develop two pharmaceutical projects: Ondansetron Oral Film and Edaravone Injection Solution, both of which have promising market prospects [1] Group 1: Project Details - The Ondansetron Oral Film is designed for the prevention and treatment of nausea and vomiting associated with chemotherapy, radiotherapy, and surgery. It is particularly suitable for individuals with swallowing difficulties as it does not require water for administration and is recommended by authoritative anti-nausea guidelines [1] - The Edaravone Injection Solution is intended for the treatment of stroke, indicating a strong market potential for this therapeutic area [1] Group 2: Collaboration and Development - The technical cooperation development contract for these projects was signed at the end of October 2025, highlighting the timeline for the collaboration [1]